Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z8HX
|
|||
| Former ID |
DNC007191
|
|||
| Drug Name |
6,7-dichloro-1H-indole-2,3-dione
|
|||
| Synonyms |
6,7-dichloro-1H-indole-2,3-dione; 18711-12-1; 6,7-Dichloroindoline-2,3-dione; 1H-Indole-2,3-dione,6,7-dichloro-; 6,7-dichloro-2,3-dihydro-1H-indole-2,3-dione; 6,7-dichlorisatin; 6,7-dichloroisatin; AC1Q3HQA; Isatin-based compound, 54; SCHEMBL1248801; CHEMBL222292; CTK4D9416; BDBM22834; DTXSID30588487; MolPort-004-304-808; XTXIILHWOQZVAQ-UHFFFAOYSA-N; STL381782; ZINC14979616; AKOS000139553; MCULE-1304306967; 1H-Indole-2,3-dione, 6,7-dichloro-; AJ-65537; KB-335070; FT-0620847; EN300-36024; Y-0718
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H3Cl2NO2
|
|||
| Canonical SMILES |
C1=CC(=C(C2=C1C(=O)C(=O)N2)Cl)Cl
|
|||
| InChI |
1S/C8H3Cl2NO2/c9-4-2-1-3-6(5(4)10)11-8(13)7(3)12/h1-2H,(H,11,12,13)
|
|||
| InChIKey |
XTXIILHWOQZVAQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 18711-12-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. J Med Chem. 2007 Apr 19;50(8):1876-85. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.